Association of initial empirical antibiotic therapy with increased risk of necrotizing enterocolitis.


Journal

European journal of pediatrics
ISSN: 1432-1076
Titre abrégé: Eur J Pediatr
Pays: Germany
ID NLM: 7603873

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 16 01 2020
accepted: 08 05 2020
revised: 29 04 2020
pubmed: 20 5 2020
medline: 24 3 2021
entrez: 20 5 2020
Statut: ppublish

Résumé

Whether the prophylactic use of antibiotics increase the risk of necrotizing enterocolitis (NEC) remains controversial. This review aims to investigate initial empirical antibiotic therapy (IEAT) and is associated with the risk of NEC. PubMed, EMBASE, Cochrane Library, and Web of Science databases were searched through March 1, 2020. All studies on the impacts of antibiotic exposure on NEC development were included. Thirteen studies including 7901 participants were selected. Two reviewers independently examined the extracted data and assessed the quality of the included studies. Random-effects model was used to pool the effect estimates. We found that IEAT (≥ 5 days) was associated with an increased risk of NEC in adjusted (Odds risk [OR] 1.51, 95% confidence interval [CI] 1.22-1.87) and unadjusted (OR 2.35, 95% CI 1.54-3.57) analyses. Sensitivity analysis also supported these findings.Conclusion: The evidence suggests an association between IEAT (≥ 5 days) and the risk of NEC. Further studies are needed to address whether the association with IEAT is causal.What is Known:•Necrotizing enterocolitis (NEC) is acute inflammatory necrosis of the intestinal tractin the newborn infant.•Some observational studies have associated initial empirical antibiotics with an increased risk of subsequent NEC.What is New:•Initial empirical antibiotic therapy (IEAT) (≥ 5 days) appear to increase the risk of NEC.

Identifiants

pubmed: 32424744
doi: 10.1007/s00431-020-03679-4
pii: 10.1007/s00431-020-03679-4
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1047-1056

Subventions

Organisme : the National Science Foundation of China
ID : 81630038
Organisme : the National Science Foundation of China
ID : 81971433
Organisme : the National Science Foundation of China
ID : 81971428
Organisme : the National Science Foundation of China
ID : 81771634
Organisme : the National Key R&D Program of China
ID : 2017YFA0104200

Références

Stoll BJ, Hansen NI, Bell EF, Walsh MC, Carlo WA, Shankaran S, Laptook AR, Sanchez PJ, Van Meurs KP, Wyckoff M, Das A, Hale EC, Ball MB, Newman NS, Schibler K, Poindexter BB, Kennedy KA, Cotten CM, Watterberg KL, D’Angio CT, DeMauro SB, Truog WE, Devaskar U, Higgins RD (2015) Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA 314:1039–1051
doi: 10.1001/jama.2015.10244
Beeby PJ, Jeffery H (1992) Risk factors for necrotising enterocolitis: the influence of gestational age. Arch Dis Child 67:432–435
doi: 10.1136/adc.67.4_Spec_No.432
Fanaroff AA, Stoll BJ, Wright LL, Carlo WA, Ehrenkranz RA, Stark AR, Bauer CR, Donovan EF, Korones SB, Laptook AR, Lemons JA, Oh W, Papile LA, Shankaran S, Stevenson DK, Tyson JE, Poole WK (2007) Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 196:141–147
doi: 10.1016/j.ajog.2006.09.014
Cotton CM (2010) Early, prolonged use of postnatal antibiotics increased the risk of necrotising enterocolitis. Arch Dis Child Educ Pract Ed 95:94
doi: 10.1136/adc.2010.187732
Abdel GE, Ali AA (2012) Empirical antibiotic treatment and the risk of necrotizing enterocolitis and death in very low birth weight neonates. Ann Saudi Med 32:521–526
doi: 10.5144/0256-4947.2012.521
Rønnestad A, Abrahamsen TG, Medbø S, Reigstad H, Lossius K, Kaaresen PI, Engelund IE, Irgens LM, Markestad T (2005) Septicemia in the first week of life in a Norwegian national cohort of extremely premature infants. Pediatrics 115:e262–e268
doi: 10.1542/peds.2004-1834
Ting JY, Synnes A, Roberts A, Deshpandey A, Dow K, Yoon EW, Lee K, Dobson S, Lee SK, Shah PS (2016) Association between antibiotic use and neonatal mortality and morbidities in very low-birth-weight infants without culture-proven sepsis or necrotizing enterocolitis. JAMA Pediatr 170:1181–1187
doi: 10.1001/jamapediatrics.2016.2132
Flannery DD, Ross RK, Mukhopadhyay S, Tribble AC, Puopolo KM, Gerber JS (2018) Temporal trends and center variation in early antibiotic use among premature infants. JAMA Netw Open 1:e180164
doi: 10.1001/jamanetworkopen.2018.0164
Egan EA, Nelson RM, Mantilla G, Eitzman DV (1977) Additional experience with routine use of oral kanamycin prophylaxis for necrotizing enterocolitis in infants under 1,500 grams. J Pediatr 90:331–332
doi: 10.1016/S0022-3476(77)80683-5
Siu Y, Ng P, Fung S, Lee C, Wong M, Fok T, So K, Cheung K, Wong W, Cheng A (1998) Double blind, randomised, placebo controlled study of oral vancomycin in prevention of necrotising enterocolitis in preterm, very low birthweight infants. Arch Dis Child-Fetal 79:F105–F109
doi: 10.1136/fn.79.2.F105
Bonnemaison E, Lanotte P, Cantagrel S, Thionois S, Quentin R, Chamboux C, Laugier J (2003) Comparison of fecal flora following administration of two antibiotic protocols for suspected maternofetal infection. Neonatology 84:304–310
doi: 10.1159/000073639
Wang Y, Hoenig JD, Malin KJ, Qamar S, Petrof EO, Sun J, Antonopoulos DA, Chang EB, Claud EC (2009) 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. The ISME journal 3:944–954
doi: 10.1038/ismej.2009.37
Moher D (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement Syst.
Walsh MC, Kliegman RM (1986) Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin N Am 33:179–201
doi: 10.1016/S0031-3955(16)34975-6
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savović J, Schulz KF, Weeks L, Sterne JA (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Bmj 343:d5928
doi: 10.1136/bmj.d5928
Wells GA, Tugwell P, O Connell D, Welch V, Peterson J, Shea B, Losos M (2015) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses.
Rostom A, Dubé C, Cranney A (2004) Assessments. Appendix D, Quality Assessment Forms
Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. Bmj 327:557–560
doi: 10.1136/bmj.327.7414.557
Alexander VN, Northrup V, Bizzarro MJ (2011) Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis. J Pediatr 159:392–397
doi: 10.1016/j.jpeds.2011.02.035
Kuppala VS, Meinzen-Derr J, Morrow AL, Schibler KR (2011) Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J Pediatr 159:720–725
doi: 10.1016/j.jpeds.2011.05.033
Tagare A, Kadam S, Vaidya U, Pandit A (2010) Routine antibiotic use in preterm neonates: a randomised controlled trial. J Hosp Infect 74:332–336
doi: 10.1016/j.jhin.2009.09.010
Esmaeilizand R, Shah PS, Seshia M, Yee W, Yoon EW, Dow K (2018) Antibiotic exposure and development of necrotizing enterocolitis in very preterm neonates. Paed Child Healt-Can 23:e56–e61
doi: 10.1093/pch/pxx169
Alsafadi TR, Alotaibi B, Banabilah H, Bukhary E, Garrada S, Alghamdi A, Almohammal M, Alshumrani N, Alqasim M, Abdulkhahar SA (2018) Does prolonged initial empirical antibiotics treatment increase morbidity and mortality in preterm infants<34 weeks? Journal of Clinical Neonatology 7:116
doi: 10.4103/jcn.JCN_86_17
Raba AA, O Sullivan A, Semberova J, Martin A, Miletin J (2019) Are antibiotics a risk factor for the development of necrotizing enterocolitis—case-control retrospective study. Eur J Pediatr 178:923–928
doi: 10.1007/s00431-019-03373-0
Afjeh S, Sabzehei M, Seyyed-Ali-Reza Fahimzad FS, Shamshiri A, Esmaili F (2016) Antibiotic therapy for very low birth weigh newborns in NICU. Iran J Pediatr 26
Torres D, Munoz T, Bancalari A, Manriquez C (2018) Prolonged initial empirical antibiotic treatment and the risk of morbidity and mortality in very low birthweight infants. Rev Chil Pediatr 89:600–605
pubmed: 30571802
Al-Mouqdad MM, Aljobair F, Alaklobi FA, Taha MY, Abdelrahim A, Asfour SS (2018) The consequences of prolonged duration of antibiotics in premature infants with suspected sepsis in a large tertiary referral hospital: a retrospective cohort study. Int J Pediatr Adoles Med 5:110–115
doi: 10.1016/j.ijpam.2018.08.003
Fajardo C, Alshaikh B, Harabor A (2019) Prolonged use of antibiotics after birth is associated with increased morbidity in preterm infants with negative cultures. J Matern Fetal Neonatal Med 32:4060–4066
doi: 10.1080/14767058.2018.1481042
Ng P, Dear P, Thomas D (1988) Oral vancomycin in prevention of necrotising enterocolitis. Arch Dis Child 63:1390–1393
doi: 10.1136/adc.63.11.1390
Yang C, Tang P, Liu P, Huang W, Chen Y, Wang H, Chang J, Lin L (2018) Maternal pregnancy-induced hypertension increases subsequent neonatal necrotizing enterocolitis risk: a nationwide population-based retrospective cohort study in Taiwan. Medicine 97
Bashiri A, Zmora E, Sheiner E, Hershkovitz R, Shoham-Vardi I, Mazor M (2003) Maternal hypertensive disorders are an independent risk factor for the development of necrotizing enterocolitis in very low birth weight infants. Fetal Diagn Ther 18:404–407
doi: 10.1159/000073132
Manogura AC, Turan O, Kush ML, Berg C, Bhide A, Turan S, Moyano D, Bower S, Nicolaides KH, Galan HL (2008) Predictors of necrotizing enterocolitis in preterm growth-restricted neonates. Am J Obstet Gynecol 198:631–638
doi: 10.1016/j.ajog.2007.11.048
Halac E, Halac J, Bégué EF, Casañas JM, Indiveri DR, Petit JF, Figueroa MJ, Olmas JM, Rodríguez LA, Obregón RJ (1990) Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: a controlled trial. J Pediatr 117:132–138
doi: 10.1016/S0022-3476(05)72461-6
Roberts D, Brown J, Medley N, Dalziel SR (2017) Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Db Syst Rev
Carter BM, Holditch-Davis D (2008) Risk factors for NEC in preterm infants: how race, gender and health status contribute. Adv Neonatal Care 8:285–290
doi: 10.1097/01.ANC.0000338019.56405.29
Fouhy F, Guinane CM, Hussey S, Wall R, Ryan CA, Dempsey EM, Murphy B, Ross RP, Fitzgerald GF, Stanton C (2012) High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin. Antimicrob Agents Ch 56:5811–5820
doi: 10.1128/AAC.00789-12
Bokulich NA, Chung J, Battaglia T, Henderson N, Jay M, Li H, Lieber AD, Wu F, Perez-Perez GI, Chen Y (2016) Antibiotics, birth mode, and diet shape microbiome maturation during early life. Sci Transl Med 8:343r–382r
doi: 10.1126/scitranslmed.aad7121
Dethlefsen L, Huse S, Sogin ML, Relman DA (2008) The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. Plos Biol 6
Yassour M, Vatanen T, Siljander H, Hämäläinen A, Härkönen T, Ryhänen SJ, Franzosa EA, Vlamakis H, Huttenhower C, Gevers D (2016) Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability. Sci Transl Med 8:343r–381r
doi: 10.1126/scitranslmed.aad0917
Gewolb IH, Schwalbe RS, Taciak VL, Harrison TS, Panigrahi P (1999) Stool microflora in extremely low birthweight infants. Arch Dis Child-Fetal 80:F167–F173
doi: 10.1136/fn.80.3.F167
Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118:229–241
doi: 10.1016/j.cell.2004.07.002
Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL (2005) An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122:107–118
doi: 10.1016/j.cell.2005.05.007
Caicedo RA, Schanler RJ, Li N, Neu J (2005) The developing intestinal ecosystem: implications for the neonate. Pediatr Res 58:625–628
doi: 10.1203/01.PDR.0000180533.09295.84
Jilling T, Simon D, Lu J, Meng FJ, Li D, Schy R, Thomson RB, Soliman A, Arditi M, Caplan MS (2006) The roles of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis. J Immunol 177:3273–3282
doi: 10.4049/jimmunol.177.5.3273
Valpacos M, Arni D, Keir A, Aspirot A, Wilde JC, Beasley S, De Luca D, Pfister RE, Karam O (2018) Diagnosis and management of necrotizing enterocolitis: an international survey of neonatologists and pediatric surgeons. Neonatology 113:170–176
doi: 10.1159/000484197

Auteurs

Pradhan Rina (P)

Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, 610041, China.
Key Laboratory of Obstetric & Gynecologic and Pediatric Diseases and Birth Defects, Ministry of Education, Sichuan University, Chengdu, 610041, China.

Yan Zeng (Y)

Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, 610041, China.
Key Laboratory of Obstetric & Gynecologic and Pediatric Diseases and Birth Defects, Ministry of Education, Sichuan University, Chengdu, 610041, China.

Junjie Ying (J)

Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, 610041, China.
Key Laboratory of Obstetric & Gynecologic and Pediatric Diseases and Birth Defects, Ministry of Education, Sichuan University, Chengdu, 610041, China.

Yi Qu (Y)

Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, 610041, China.
Key Laboratory of Obstetric & Gynecologic and Pediatric Diseases and Birth Defects, Ministry of Education, Sichuan University, Chengdu, 610041, China.

Dezhi Mu (D)

Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, 610041, China. mudz@scu.edu.cn.
Key Laboratory of Obstetric & Gynecologic and Pediatric Diseases and Birth Defects, Ministry of Education, Sichuan University, Chengdu, 610041, China. mudz@scu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH